Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
Avidity Biosciences Director Sells $3.8M in Stockby Mark Eisenberg 15.06.2024Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...
DallasNews Chief Invests $26K in Stock Amid Cash Woesby Mark Eisenberg 15.06.2024Murray acquires 7,000+ DallasNews shares; exacting prices and Q2 earnings update ahead amid cash burn and unprofitability concerns.
Tempus AI Raises $410M in IPO, Sees Revenue Surgeby Mark Eisenberg 15.06.2024Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...
Primoris Director Sells $209K in Shares Amid Growth Plansby Mark Eisenberg 15.06.2024Mashinski’s sale of shares valued at $209,371 adjusts her Primoris stake to 20,454 shares, per SEC Form 4. Primoris targets ...
Elon Musk’s Plan: Cut Jobs, Boost Bonusby Mark Eisenberg 25.04.2024Tesla faces tough times ahead as they lay off 10% of their staff, but CEO Elon Musk assures that corrections ...
Stock Market Woes: PCE Reading and Big Tech Earnings Analysisby Terry Bingman 25.04.2024The market rally is facing a fragile state as S&P 500 closes below 5,000 and Nasdaq drops over 5% on ...
Top Wall Street Analysts Recommend 3 Dividend Stocksby Mark Eisenberg 25.04.2024Scotto, Biggar, and Liani rank among top analysts with profitable ratings & impressive average returns, according to TipRanks data. Cisco ...
Invest in Invesco S&P 500 Garp ETFby Mark Eisenberg 25.04.2024Discover an ETF with a proven history of outperforming the S&P 500. Should you invest $1,000 in Invesco GARP ETF? ...
3 Surprising Tech Stocks Billionaires Loveby Mark Eisenberg 25.04.2024Nvidia is one of the top companies in the list, including Millennium Management, The Children's Investment Fund, and Soros Fund ...